Evidence map›Paper›PMID 39077103›Full record

ArticleReviews in cardiovascular medicine2023

Predictive Value of the Fibrinogen to Gamma-Glutamine Transferase Ratio in the Long-Term Outcome in Patients with Coronary Heart Disease: A Retrospective Cohort Study.

Ju Yan, Chang-Jiang Deng, Xuan Min, Yi Ning, Ming-Yuan Wang, Si-Fan Wang, Mikereyi Aimaitijiang, Ying-Ying Zheng, Xiang Xie, Yi-Tong Ma

Abstract read
In one paragraph

Article in Reviews in cardiovascular medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Ju YanDepartment of Cardiology, The First Affiliated Hospital of Xinjiang Medical University, 830054 Urumqi, Xinjiang, China.
Chang-Jiang DengDepartment of Cardiology, The First Affiliated Hospital of Xinjiang Medical University, 830054 Urumqi, Xinjiang, China.
Xuan MinDepartment of Cardiology, The First Affiliated Hospital of Xinjiang Medical University, 830054 Urumqi, Xinjiang, China.
Yi NingDepartment of Cardiology, The First Affiliated Hospital of Xinjiang Medical University, 830054 Urumqi, Xinjiang, China.
Ming-Yuan WangDepartment of Cardiology, The First Affiliated Hospital of Xinjiang Medical University, 830054 Urumqi, Xinjiang, China.
Si-Fan WangDepartment of Cardiology, The First Affiliated Hospital of Xinjiang Medical University, 830054 Urumqi, Xinjiang, China.
Mikereyi AimaitijiangDepartment of Cardiology, The First Affiliated Hospital of Xinjiang Medical University, 830054 Urumqi, Xinjiang, China.
Ying-Ying ZhengDepartment of Cardiology, The First Affiliated Hospital of Xinjiang Medical University, 830054 Urumqi, Xinjiang, China.
Xiang XieDepartment of Cardiology, The First Affiliated Hospital of Xinjiang Medical University, 830054 Urumqi, Xinjiang, China.
Yi-Tong MaDepartment of Cardiology, The First Affiliated Hospital of Xinjiang Medical University, 830054 Urumqi, Xinjiang, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The ratio of fibrinogen to Methods: A total of 5638 patients with CHD who were hospitalized from January 2008 to December 2016 were retrospectively enrolled in the study. The mean follow-up time was 35.9 Results: The optimal cut-off value was determined via a ROC analysis (FGR = 1.22, Conclusions: High FGR can increase the risk of MACCE in patients with CHD; additionally, it can be used as a new biomarker for long-term prognosis in CHD patients. Clinical Trial Registration: All details of this study are registered on the website (http://www.chictr.org.cn), registration number: ChiCTR-ORC-16010153.

Indexed as

coronary heart disease (CHD)fibrinogenfibrinogen/γ-glutamine transferase (FGR)long-term outcomemortalityγ-glutamine transferase

Identifiers

PMID39077103
PMCPMC11272865

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.